1.27
Canopy Growth Corporation stock is traded at $1.27, with a volume of 16.91M.
It is up +2.42% in the last 24 hours and up +1.60% over the past month.
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
See More
Previous Close:
$1.24
Open:
$1.25
24h Volume:
16.91M
Relative Volume:
1.28
Market Cap:
$304.61M
Revenue:
$211.87M
Net Income/Loss:
$-551.61M
P/E Ratio:
-0.1861
EPS:
-6.8241
Net Cash Flow:
$-140.45M
1W Performance:
-2.31%
1M Performance:
+1.60%
6M Performance:
-22.09%
1Y Performance:
-79.32%
Canopy Growth Corporation Stock (CGC) Company Profile
Name
Canopy Growth Corporation
Sector
Phone
855-558-9333
Address
1 Hershey Drive, Smiths Falls, ON
Compare CGC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
CGC
Canopy Growth Corporation
|
1.27 | 328.59M | 211.87M | -551.61M | -140.45M | -6.8241 |
![]()
ZTS
Zoetis Inc
|
156.62 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.52 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
![]()
HLN
Haleon Plc Adr
|
9.82 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.46 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
![]()
UTHR
United Therapeutics Corp
|
312.23 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Canopy Growth Corporation Stock (CGC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Apr-04-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
Nov-02-22 | Initiated | Bernstein | Underperform |
Oct-26-22 | Upgrade | Canaccord Genuity | Sell → Hold |
Jun-08-22 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
Mar-22-22 | Downgrade | Barclays | Equal Weight → Underweight |
Dec-22-21 | Downgrade | BofA Securities | Neutral → Underperform |
Dec-20-21 | Downgrade | Piper Sandler | Neutral → Underweight |
Dec-07-21 | Initiated | Wells Fargo | Underweight |
Nov-18-21 | Initiated | Barclays | Equal Weight |
Nov-08-21 | Downgrade | CIBC | Neutral → Sector Underperform |
Nov-08-21 | Downgrade | Canaccord Genuity | Hold → Sell |
Nov-08-21 | Downgrade | Cowen | Outperform → Market Perform |
Oct-01-21 | Downgrade | BofA Securities | Buy → Neutral |
Aug-12-21 | Upgrade | Jefferies | Underperform → Hold |
Jun-02-21 | Upgrade | Canaccord Genuity | Sell → Hold |
May-25-21 | Upgrade | MKM Partners | Neutral → Buy |
Apr-28-21 | Resumed | BofA Securities | Buy |
Feb-24-21 | Downgrade | Jefferies | Hold → Underperform |
Feb-10-21 | Downgrade | Canaccord Genuity | Hold → Sell |
Feb-10-21 | Downgrade | The Benchmark Company | Buy → Hold |
Feb-05-21 | Downgrade | Piper Sandler | Overweight → Neutral |
Sep-04-20 | Upgrade | CFRA | Buy → Strong Buy |
Jun-01-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
Jun-01-20 | Downgrade | Bryan Garnier | Neutral → Sell |
Jun-01-20 | Downgrade | CIBC | Sector Outperform → Neutral |
Jun-01-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
Jun-01-20 | Downgrade | Stifel | Buy → Sell |
May-22-20 | Resumed | BofA/Merrill | Buy |
Apr-16-20 | Upgrade | Jefferies | Underperform → Hold |
Jan-28-20 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
Dec-12-19 | Reiterated | Cantor Fitzgerald | Neutral |
Nov-20-19 | Upgrade | BofA/Merrill | Neutral → Buy |
Nov-15-19 | Downgrade | Alliance Global Partners | Buy → Neutral |
Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
Oct-14-19 | Downgrade | Seaport Global Securities | Buy → Neutral |
Oct-11-19 | Downgrade | Jefferies | Hold → Underperform |
Sep-27-19 | Downgrade | BofA/Merrill | Buy → Neutral |
Sep-20-19 | Initiated | MKM Partners | Neutral |
Sep-18-19 | Initiated | Oppenheimer | Perform |
Aug-26-19 | Upgrade | Seaport Global Securities | Neutral → Buy |
Jul-17-19 | Initiated | Ladenburg Thalmann | Buy |
View All
Canopy Growth Corporation Stock (CGC) Latest News
Cannabis Stocks To Follow TodayAugust 19th - MarketBeat
This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors - ca.finance.yahoo.com
Canopy Growth Corporation Struggles With Losses Amidst Financial Challenge - timothysykes.com
Canopy Growth Corporation (CGC) Growth Accelerates U.S. Expansion with Major Acquisitions - MSN
Canopy Growth Corporation’s Beta Climbs After Market VolatilityJuly 2025 PreEarnings & Breakout Confirmation Alerts - newsimpact.co.kr
Promising Cannabis Stocks To Add to Your WatchlistAugust 17th - MarketBeat
Canopy USA appoints Casey Rash as chief financial officer - MarketScreener
Canopy Growth appoints new executive team - TipRanks
Canopy USA names new executive team for expansion - StreetInsider
Major Cannabis Leadership Shake-Up: Canopy USA Builds All-Star Executive Team for National Expansion - Stock Titan
Canopy Growth Urges Shareholders to Vote in Upcoming Meeting - MSN
Canopy Growth Corporation Faces Volatility Amid Earnings Concerns - timothysykes.com
Published on: 2025-08-17 13:46:32 - sundaytimes.kr
U.S. federal cannabis rescheduling: A game-changer for Canopy Growth? - MSN
Published on: 2025-08-17 09:48:24 - mustnews.co.kr
Best Cannabis Stocks To Follow TodayAugust 15th - MarketBeat
Here is What to Know Beyond Why Canopy Growth Corporation (CGC) is a Trending Stock - MSN
Im Cannabis Corp. shares rise 1.13% intraday after Canopy Growth announced its 2025 annual general and special meeting of shareholders. - AInvest
Unexpected Surge: Canopy Growth Corporation Analysis - StocksToTrade
New Bill: Representative W. Gregory Steube introduces H.R. 4963: Marijuana 1-to-3 Act of 2025 - Quiver Quantitative
Can Canopy Growth Corporation disrupt its industryPortfolio Performance Report & AI Powered Buy and Sell Recommendations - classian.co.kr
Canopy Growth Announces Mailing and Filing of Proxy Materials for Annual General and Special Meeting and Urges All Shareholders to Vote Now - MarketScreener
Critical 33.3% Quorum Needed: Canopy Growth's Annual Meeting Includes Reverse Stock Split Vote - Stock Titan
Canopy Growth Corporation shares rise 5.37% premarket after Invivyd's FDA alignment on rapid pathway for COVID-19 vaccine alternative. - AInvest
U.S. federal cannabis rescheduling: A game-changer for Canopy Growth? | 2025-08-15 | Investing News - Stockhouse
Options Data Show Bullish Bias in Canopy Growth CorporationDollar Strength & Fast Moving Stock Watchlists - newsyoung.net
In-Depth Analysis of Canopy Growth Corporation’s Financial Landscape - StocksToTrade
Canopy Growth’s Earnings Call: Mixed Sentiments and Strategic Moves - The Globe and Mail
Canopy Growth: Soaring or Sinking? - timothysykes.com
Canopy Growth Corporation shares rise 2.44% after-hours following Hilton's announcement of Canopy by Hilton Makati opening in 2026. - AInvest
Canopy Growth Stock Surge: Timing for Buying? - StocksToTrade
CGC Stock: Unexpected Surge, Buying Opportunity? - timothysykes.com
Canopy Growth reports higher cannabis sales but posts multi-million dollar loss - Lanarkleedstoday.ca
Cannabis ETFs Light Up As Trump Eyes Marijuana Reclassification - Benzinga
Does Canopy Growth Corporation have declining or rising EPSHigh Octane Equity Watchlist - thegnnews.com
Promising Cannabis Stocks To Keep An Eye OnAugust 12th - MarketBeat
Cannabis MSOs cool after rally driven by rescheduling hopes - Seeking Alpha
Explainer: How US marijuana reclassification could help cannabis companies - Reuters
Cannabis ETFs Soar as Trump Mulls Over Marijuana Reclassification - Yahoo Finance
Canopy Growth launches 7ACRES in Australia - MMJDaily
The Canopy, TerrAscend, and Village Farms Earnings Breakdown - The Dales Report
Canopy Growth Corporation (NASDAQ:CGC) Q1 2026 Earnings Call Transcript - Insider Monkey
Canopy Growth, Silver North Resources, Vonovia – Clear signals | 2025-08-12 | Investing News - Stockhouse
Canopy Growth shares surge 13.92% in premarket after Trump considers reclassifying cannabis and company reports strong Q1 earnings. - AInvest
Canopy Growth Soars 12.03% on Trump's Marijuana Rescheduling Consideration - AInvest
Tilray Surges 14% After Hours On Trump Cannabis Reclassification - Benzinga
Cronos Rallies Amidst Greater Cannabis Sector Rally Over Possible Rescheduling (CRON) - Seeking Alpha
Canopy Growth Q1 Revenue Jumps on Strong Cannabis Sales - Tobacco Reporter
Canopy Growth Rallies On News Of Possible Rescheduling From Trump - Seeking Alpha
Pot Stocks Soar As Trump Considers Drug Reclassification - FA Mag
Cannabis stocks spike as Trump signals possible reclassification - The Globe and Mail
Canopy Growth Corporation Stock (CGC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Canopy Growth Corporation Stock (CGC) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Kruh Willy | Director |
Jun 30 '25 |
Sale |
1.23 |
10,468 |
12,876 |
73,390 |
Lazzarato David Angelo | Director |
Jun 30 '25 |
Sale |
1.23 |
15,701 |
19,312 |
119,064 |
Hong Judy Eun Joo | Chief Financial Officer |
Jun 16 '25 |
Sale |
1.63 |
38,678 |
62,866 |
579,889 |
Gedeon Christelle | See Remarks |
Jun 16 '25 |
Sale |
1.47 |
9,555 |
14,046 |
389,945 |
Yanofsky Theresa | Director |
Mar 31 '25 |
Sale |
0.92 |
2,004 |
1,844 |
20,199 |
Lazzarato David Angelo | Director |
Mar 31 '25 |
Sale |
0.92 |
3,004 |
2,764 |
22,886 |
Kruh Willy | Director |
Mar 31 '25 |
Sale |
0.92 |
2,012 |
1,851 |
9,272 |
Kruh Willy | Director |
Dec 31 '24 |
Sale |
2.67 |
2,004 |
5,351 |
11,284 |
Yanofsky Theresa | Director |
Dec 31 '24 |
Sale |
2.67 |
1,996 |
5,329 |
22,203 |
Mongeau Luc | Director |
Dec 31 '24 |
Sale |
2.67 |
2,004 |
5,351 |
11,277 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):